Litcius/Paper detail

Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial

Abigail S. Baldridge, Mark D. Huffman, Danielle Lazar, Hiba Abbas, Fallon M. Flowers, Adriana Quintana, Alema Jackson, Sadiya S. Khan, Aashima Chopra, My H. Vu, Priya Tripathi, Tyler Jacobson, Olutobi Adekunle Sanuade, Namratha R. Kandula, Stephen D. Persell, James Paparello, Linda Rosul, Jairo Mejia, Donald M. Lloyd‐Jones, Clara K Chow, Jody D. Ciolino

2022American Heart Journal15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdverse effectBlood pressureRandomized controlled trialClinical trialInternal medicineBlood Pressure and Hypertension StudiesSodium Intake and HealthMedication Adherence and Compliance
Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial | Litcius